Metabolic Imaging of Ischemic Stroke: The Present and Future
Authors:
Open Access
- 10 April 2014
- journal article
- review article
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 35 (Supplement) , S37-S43
Abstract
SUMMARY: Measures of cerebral metabolism may be useful in the selection of patients for reperfusion therapies and as end points in clinical trials. However, there are currently no clinically routine techniques that provide such data directly. We review how imaging modalities in current clinical use may provide surrogate markers of metabolic activity. Promising techniques for metabolic imaging that are currently in the pipeline are reviewed.Keywords
This publication has 59 references indexed in Scilit:
- Positron emission tomography with 11C-flumazenil in the rat shows preservation of binding sites during the acute phase after 2h-transient focal ischemiaNeuroscience, 2011
- ‘Salvaged’ Stroke Ischaemic Penumbra Shows Significant Injury: Studies with the Hypoxia Tracer FMISOJournal of Cerebral Blood Flow & Metabolism, 2010
- Early [ 11 C]Flumazenil/H 2 O Positron Emission Tomography Predicts Irreversible Ischemic Cortical Damage in Stroke Patients Receiving Acute Thrombolytic TherapyStroke, 2000
- Identifying hypoxic tissue after acute ischemic stroke using PET and 18 F-fluoromisonidazoleNeurology, 1998
- Spontaneous neurological recovery after stroke and the fate of the ischemic penumbraAnnals of Neurology, 1996
- Prolonged Persistence of Substantial Volumes of Potentially Viable Brain Tissue After StrokeStroke, 1996
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: relation to outcomeThe Lancet, 1993
- Progressive Derangement of Periinfarct Viable Tissue in Ischemic StrokeJournal of Cerebral Blood Flow & Metabolism, 1992
- Thresholds in cerebral ischemia - the ischemic penumbra.Stroke, 1981